NES
CBST

New England Securities’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

New England Securities’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,221
Closed -$89K – 1915
2014
Q1 		$89K Hold
1,221
– – 0.03% 410
2013
Q4 		$84K Sell
1,221
-1,229
-50% -$79.6K 0.03% 434
2013
Q3 		$156K Hold
2,450
– – 0.08% 262
2013
Q2 		$118K Buy
+2,450
New +$120K 0.08% 258

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

New England Securities's CBST Position: Q2 2014 in Review

New England Securities sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 1,221 shares — an estimated $89K sold.

New England Securities first reported a position in CBST in Q2 2013 and held it in 4 quarters. The position peaked at $156K in Q3 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • New England Securities reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • New England Securities sold 1,221 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $89K.
  • New England Securities first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • New England Securities's CUBIST PHARMACEUTICALS INC position peaked at $156K in Q3 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on New England Securities's 13F filing for Q2 2014, filed 4 Aug 2014.